<?xml version="1.0" encoding="UTF-8"?>
<p id="Par69">Three anti-HIV drugs, ritonavir, lopinavir, and darunavir, might have a therapeutic impact on coronavirus disease 2019 (COVID-19). It is implied that the therapeutic effect of ritonavir and lopinavir on COVID-19 may be largely due to their inhibitory impact on CEP_C30 (coronavirus endopeptidase C30), while ritonavir may have greater ability; the inhibitory impact of darunavir on SARS-CoV-2 and its potential therapeutic influence may be largely due to its inhibitory effect on PLVP(papain-like viral protease) [
 <xref ref-type="bibr" rid="CR73">73</xref>].
</p>
